Geordon A Frere

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Human Serum Albumin

Duchenne Muscular Dystrophy

Top Venues

Journal of the American Chemical Society

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Geordon A Frere, Advait Hasabnis, Camila B Francisco, Motasem Suleiman, Olga Alimowska, Rima Rahmatullah, Jerome Gould, Celia Yi-Chia Su, Oleksandr Voznyy, Patrick Thomas Gunning, Ernani Abicht Basso, Robert Scott Prosser
Next-Generation Tags for Fluorine Nuclear Magnetic Resonance: Designing Amplification of Chemical Shift Sensitivity. Journal of the American Chemical Society 146 (5) (2024)
Geordon A Frere, Advait Hasabnis, Camila B Francisco, Motasem Suleiman, Olga Alimowska, Rima Rahmatullah, Jerome Gould, Celia Yi-Chia Su, Oleksandr Voznyy, Patrick Thomas Gunning, Ernani Abicht Basso, Robert Scott Prosser
Next-Generation Tags for Fluorine Nuclear Magnetic Resonance: Designing Amplification of Chemical Shift Sensitivity. Journal of the American Chemical Society 146 (5) (2024)
Geordon A Frere, Advait Hasabnis, Camila B Francisco, Motasem Suleiman, Olga Alimowska, Rima Rahmatullah, Jerome Gould, Celia Yi-Chia Su, Oleksandr Voznyy, Patrick Thomas Gunning, Ernani Abicht Basso, Robert Scott Prosser
Next-Generation Tags for Fluorine Nuclear Magnetic Resonance: Designing Amplification of Chemical Shift Sensitivity. Journal of the American Chemical Society (2024)
Geordon A Frere, Advait Hasabnis, Camila B Francisco, Motasem Suleiman, Olga Alimowska, Rima Rahmatullah, Jerome Gould, Celia Yi-Chia Su, Oleksandr Voznyy, Patrick Thomas Gunning, Ernani Abicht Basso, Robert Scott Prosser
Next-Generation Tags for Fluorine Nuclear Magnetic Resonance: Designing Amplification of Chemical Shift Sensitivity. Journal of the American Chemical Society 146 (5) (2024)
Yasir S Raouf, Abootaleb Sedighi, Mulu Geletu, Geordon A Frere, Rebecca G Allan, Nabanita Nawar, Elvin D de Araujo, Patrick Thomas Gunning
Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular Dystrophy. Journal of medicinal chemistry (2023)